Patents by Inventor Simon A. Thomas

Simon A. Thomas has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220242965
    Abstract: The present invention provides a cell which expresses a chimeric antigen receptor (CAR) or engineered T-cell receptor (TCR) and secretes an agent which blocks or reduces the activity of an ectoenzyme. The cells may be used in adoptive immunotherapy approaches for the treatment of diseases such as cancer.
    Type: Application
    Filed: May 1, 2020
    Publication date: August 4, 2022
    Inventors: Martin Pulé, Shaun Cordoba, Simon Thomas, Shimobi Onuoha, Reyisa Bughda, Mathieu Ferrari, Zulaikha Akbar
  • Publication number: 20220211830
    Abstract: The present invention provides a cell which comprises; (i) a chimeric antigen receptor (CAR) or a transgenic T-cell receptor (TCR); and (ii) at least one polypeptide capable of co-localizing an MHC class I polypeptide or an MHC class II polypeptide with an intracellular signalling domain within the cell.
    Type: Application
    Filed: April 7, 2020
    Publication date: July 7, 2022
    Inventors: Martin Pulé, Shaun Cordoba, Simon Thomas, Shimobi Onuoha, James Sillibourne, Farhaan Parekh
  • Publication number: 20220178872
    Abstract: The present invention relates to a method of forming a material on a graphene layer structure 5 for injecting charge into, or extracting charge out of, the graphene layer structure 5, the method comprising: providing a graphene layer structure 5 having one or more first portions 25 on a non-metallic substrate 10, said one or more first portions 25 having one or more surface defects comprising excess out-of-plane material 15; plasma etching the one or more first portions 25 of the graphene layer structure 5 to remove the out-of-plane material 15; depositing a material 30 for injecting charge into, or extracting charge out of, the graphene layer structure 5 onto the one or more plasma-etched first portions 25.
    Type: Application
    Filed: November 23, 2021
    Publication date: June 9, 2022
    Applicant: PARAGRAF LIMITED
    Inventors: Lok Yi Lee, Hugh Glass, Simon Thomas, Ivor Guiney
  • Patent number: 11345734
    Abstract: The present invention relates to a cell which comprises a chimeric antigen receptor (CAR) and a signal transduction modifying protein, selected from one of the following: (i) a truncated protein which comprises an SH2 domain from a protein which binds a phosphorylated immunoreceptor tyrosine-based activation motif (ITAM), but lacks a kinase domain; (ii) a truncated protein which comprises an SH2 domain from a protein which binds a phosphorylated immunoreceptor tyrosine-based inhibition motif (ITIM) but lacks a phosphatase domain; (iii) a fusion protein which comprises (a) an SH2 domain from a protein which binds a phosphorylated immunoreceptor tyrosine-based activation motif (ITAM) or from a protein which binds a phosphorylated immunoreceptor tyrosine-based inhibition motif (ITIM); and (ii) a heterologous domain.
    Type: Grant
    Filed: May 31, 2016
    Date of Patent: May 31, 2022
    Assignee: AUTOLUS LIMITED
    Inventors: Martin Pulé, Shaun Cordoba, Simon Thomas, Khai Kong
  • Patent number: 11347509
    Abstract: Methods of encoding and decoding are described which use a variable number of instruction words to encode instructions from an instruction set, such that different instructions within the instruction set may be encoded using different numbers of instruction words. To encode an instruction, the bits within the instruction are reordered and formed into instruction words based upon their variance as determined using empirical or simulation data. The bits in the instruction words are compared to corresponding predicted values and some or all of the instruction words that match the predicted values are omitted from the encoded instruction.
    Type: Grant
    Filed: February 12, 2020
    Date of Patent: May 31, 2022
    Assignee: Imagination Technologies Limited
    Inventors: Simon Thomas Nield, James McCarthy
  • Publication number: 20220098300
    Abstract: The present disclosure relates to anti-TRBC1 antigen binding domains characterized by the sequences of the variable chains. The CDRs sequences of the variable chains are: (VH CDR1) GYTFT, (VH CDR2) NPYNDDIQS, (VH CDR3) GAGY-NFDGAYRFFDF; and (VL CDR1) RSSQRLVHSNGNTYL, (VL CDR2) RVSNRFP, (VL CDR3) SQSTHVPYT. The claimed humanized antibodies derive from the murine JOVI antibody. Uses in cancer therapy.
    Type: Application
    Filed: October 12, 2021
    Publication date: March 31, 2022
    Inventors: Shaun Cordoba, Simon Thomas, Shimobi Onuoha, Ram Jha, Wen Chean Lim
  • Publication number: 20220102501
    Abstract: The present invention provides a method for the formation of graphene on a silicon substrate, the method comprising: (i) providing a silicon wafer having a growth surface which is free of native oxides, in a reaction chamber; (ii) nitriding the growth surface with a nitrogen-containing gas with the wafer at a temperature in excess of 800° C., to thereby form a silicon nitride layer; and (iii) forming a graphene mono-layer or multiple layer structure on the silicon nitride layer; wherein the method is performed in-situ and sequentially in the reaction chamber. The present invention also provides a graphene-on-silicon layer structure having an intervening silicon nitride layer and free of any intervening native oxide layer.
    Type: Application
    Filed: September 24, 2021
    Publication date: March 31, 2022
    Applicant: PARAGRAF LIMITED
    Inventors: Sebastian Dixon, Ivor Guiney, Simon Thomas
  • Publication number: 20220102525
    Abstract: There is provided a method of manufacturing a transistor, the method comprising: (a) providing a substrate having a semiconductor surface; (b) providing a graphene layer structure on a first portion of the semiconductor surface, wherein the graphene layer structure has a thickness of n graphene monolayers, wherein n is at least 2; (c) etching a first portion of the graphene layer structure to reduce the thickness of the graphene layer structure in said first portion to from n?1 to 1 graphene monolayers; (d) forming a layer of dielectric material on the first portion of the graphene layer structure; and (e) providing: a source contact on a second portion of the graphene layer structure; a gate contact on the layer of dielectric material; and a drain contact on a second portion of the semiconductor surface of the substrate.
    Type: Application
    Filed: September 13, 2021
    Publication date: March 31, 2022
    Applicant: PARAGRAF LIMITED
    Inventors: Thomas James Badcock, Robert Wallis, Ivor Guiney, Simon Thomas
  • Publication number: 20220102526
    Abstract: The present invention provides a method of manufacturing a graphene transistor 101, the method comprising: (a) providing a substrate having a substantially flat surface, wherein the surface comprises an insulating region 110 and an adjacent semiconducting region 105; (b) forming a graphene layer structure 115 on the surface, wherein the graphene layer structure is disposed on and across a portion of both the insulating region and the adjacent semiconducting region; (c) forming a layer of dielectric material 120 on a portion of the graphene layer structure which is itself disposed on the semiconducting region 105; and (d) providing: a source contact 125 on a portion of the graphene layer structure which is itself disposed on the insulating region 110; a gate contact 130 on the layer of dielectric material 120 and above a portion of the graphene layer structure which is itself disposed on the semiconducting region 105; and a drain contact 135 on the semiconducting region 105 of the substrate surface.
    Type: Application
    Filed: September 17, 2021
    Publication date: March 31, 2022
    Applicant: PARAGRAF LIMITED
    Inventors: Thomas James Badcock, Robert Wallis, Ivor Guiney, Simon Thomas
  • Patent number: 11290033
    Abstract: An array of graphene sheets configured to generate electricity from a flow of an ion-containing fluid, wherein the array comprises a plurality of graphene sheets, each graphene sheet comprising first and second electrical contacts, having a surface extending between the first and second electrical contacts for contacting the flow of ion-containing fluid, and wherein each graphene sheet is in electrical contact with at least a further graphene sheet.
    Type: Grant
    Filed: March 26, 2019
    Date of Patent: March 29, 2022
    Assignee: Paragraf Limited
    Inventors: Simon Thomas, Ivor Guiney
  • Publication number: 20220093852
    Abstract: Methods of providing an air- and/or moisture-barrier coating on at least a portion of a two-dimensional material are described. In particular, the methods provide an improved approach for providing a doped two-dimensional material, preferably graphene, on a substrate wherein at least a portion of the two-dimensional material is coated with an air- and/or moisture-barrier coating that comprises an inorganic oxide, fluoride or sulfide. Two-dimensional materials provided with an air- and/or moisture impermeable inorganic oxide, fluoride or sulfide coating and an electronic device comprising the same are also described.
    Type: Application
    Filed: August 25, 2021
    Publication date: March 24, 2022
    Applicant: PARAGRAF LIMITED
    Inventors: Robert Wallis, Hugh Glass, Martin Tyler, Simon Thomas, Ivor Guiney
  • Publication number: 20220056407
    Abstract: The present invention provides an engineered cell, such as a T-cell, which expresses a chimeric antigen receptor (CAR) or an engineered T-cell receptor (TCR) and one or more enzymes which, when secreted or expressed at the cell surface causes depletion of a molecule extracellular to the engineered cell; wherein said molecule is selected from: an amino acid; a nucleotide or nucleoside; or a lipid.
    Type: Application
    Filed: December 13, 2019
    Publication date: February 24, 2022
    Inventors: Paul Smith, Martin Pulé, Simon Thomas, Isaac Gannon
  • Publication number: 20220041718
    Abstract: The present invention provides a variant antigen-binding domain which comprises at least one mutation in the VH domain compared to a reference antibody and which displays an increased affinity for TRBC2 over the reference antibody. It further provides an antibody, a chimeric antigen receptor (CAR), and a bispecific T-cell engager (BiTE), a cell which comprises said CAR, and a conjugate comprising said variant antigen-binding domain or said antibody. Additionally, it provides medical uses, diagnostic methods and methods of personalised medicine that exploit the products of the invention.
    Type: Application
    Filed: October 31, 2018
    Publication date: February 10, 2022
    Inventors: Anna Bulek, Martin Pulé, Shaun Cordoba, Simon Thomas, Shimobi Onuoha, Mathieu Ferrari, Vania Baldan
  • Publication number: 20220033509
    Abstract: The present invention provides a chimeric antigen receptor (CAR) which binds a low density target antigen, which comprises a Fab antigen binding domain. The invention also relates to cells expressing such a CAR and their use in the treatment of disease.
    Type: Application
    Filed: September 26, 2019
    Publication date: February 3, 2022
    Inventors: Martin Pulé, Shaun Cordoba, Simon Thomas, Shimobi Onuoha, Mathieu Feerari, Wen Chean Lim, Biao Ma
  • Publication number: 20210403596
    Abstract: Provision of a chimeric antigen receptor (CAR) comprising a disialoganglioside (GD2)-binding domain which comprises •a) a heavy chain variable region (VH) having complementarity determining regions (CDRs) with the following sequences: •b) a light chain variable region (VL) having CDRs with the following sequences: T cells expressing such a CAR are useful in the treatment of some cancers.
    Type: Application
    Filed: March 9, 2021
    Publication date: December 30, 2021
    Inventors: Martin Pulé, John Anderson, Simon Thomas
  • Publication number: 20210363217
    Abstract: The present invention provides a cell which expresses: (i) an intracellular single domain protein binder which binds a target protein and modulates an intracellular signalling pathway; and (ii) a chimeric antigen receptor (CAR) or a transgenic T cell receptor (TCR).
    Type: Application
    Filed: June 19, 2019
    Publication date: November 25, 2021
    Inventors: Martin Pulé, Shimobi Onuoha, Shaun Cordoba, Simon Thomas, Lenart Senicar, Mathieu Ferrari
  • Patent number: 11180553
    Abstract: The present invention provides a chimeric antigen receptor (CAR) which binds human CD22, having an antigen-binding domain which comprises a) a heavy chain variable region (VH) having complementarity determining regions (CDRs) with the following sequences: CDR1—NYWIH (SEQ ID No. 1); CDR2—GINPGNNYATYRRKFQG (SEQ ID No. 2) CDR3—EGYGNYGAWFAY (SEQ ID No. 3); and b) a light chain variable region (VL) having CDRs with the following sequences: CDR1—RSSQSLANSYGNTFLS (SEQ ID No. 4); CDR2—GISNRFS (SEQ ID No. 5) CDR3—LQGTHQPYT (SEQ ID No. 6). The present invention also provides a cell comprising such a CAR and the use of such a cell to treat cancer.
    Type: Grant
    Filed: June 15, 2017
    Date of Patent: November 23, 2021
    Assignee: AUTOLUS LIMITED
    Inventors: Shimobi Onuoha, Martin Pulé, Simon Thomas, Shaun Cordoba, Evangelia Kokalaki
  • Patent number: 11091532
    Abstract: The present invention provides a cell which co-expresses a first chimeric antigen receptor (CAR) and second CAR at the cell surface, each CAR comprising an antigen-binding domain, wherein the antigen-binding domain of the first CAR binds to CD19 and the antigen-binding domain of the second CAR binds to CD22.
    Type: Grant
    Filed: December 23, 2015
    Date of Patent: August 17, 2021
    Assignee: AUTOLUS LIMITED
    Inventors: Martin Pulé, Shaun Cordoba, Shimobi Onuoha, Simon Thomas
  • Publication number: 20210244762
    Abstract: The present invention relates to a cell which comprises a chimeric antigen receptor (CAR) or transgenic T cell receptor (TCR) and secretes an antibody which binds a transforming growth factor beta receptor (T?R).
    Type: Application
    Filed: May 10, 2019
    Publication date: August 12, 2021
    Inventors: Martin Pulé, Shaun Cordoba, Shimobi Onuoha, Alex Kinna, Simon Thomas, Mathieu Ferrari, Marco Della Peruta, Phillip Wu
  • Patent number: 11085219
    Abstract: A drive for a leaf of a door, window, or the like, including a mechanical energy store (16) configured to store energy during an opening movement of the leaf and expend energy during a closing movement of the leaf, an electric motor (18) operatively connected to the leaf via a motor shaft (20), the electric motor (18) operated as a generator to dampen the opening movement and the closing movement. The electric motor including a control unit configured to control the electric motor, wherein a drive behavior of the control unit is repeatedly and variably adaptable to a current need of a user.
    Type: Grant
    Filed: February 6, 2018
    Date of Patent: August 10, 2021
    Assignee: Geze GmbH
    Inventors: Matthias Hucker, Simon Burghard, Dirk Huber, Thomas Schüler, Jörg Evertz, Simon Thomas Hasenfratz, Remo Sommer